Ultrasound-Guided Injection Therapy of Achilles Tendinopathy With Platelet-Rich Plasma or Saline: A Randomized, Blinded, Placebo-Controlled Trial

被引:92
|
作者
Krogh, Thoger P. [1 ]
Ellingsen, Torkell [1 ,2 ]
Christensen, Robin [1 ,3 ]
Jensen, Pia [1 ]
Fredberg, Ulrich [1 ,2 ]
机构
[1] Reg Hosp Silkeborg, Ctr Diagnost, Falkevej 1, DK-8600 Silkeborg, Denmark
[2] Odense Univ Hosp, Dept Rheumatol, Odense, Denmark
[3] Bispebjerg & Frederiksberg Hosp, Musculoskeletal Stat Unit, Parker Inst, Dept Rheumatol, Frederiksberg, Denmark
来源
AMERICAN JOURNAL OF SPORTS MEDICINE | 2016年 / 44卷 / 08期
关键词
Achilles; tendinopathy; tendinosis; growth factors; platelet-rich plasma; ultrasonography; injection therapy; VISA-A; randomized controlled trial; LATERAL EPICONDYLITIS; TENDON THICKNESS; ULTRASONOGRAPHY; NEOVASCULARIZATION; RELIABILITY; MANAGEMENT; REPAIR;
D O I
10.1177/0363546516647958
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Achilles tendinopathy (AT) is a common and difficult to treat musculoskeletal disorder. Purpose: To examine whether 1 injection of platelet-rich plasma (PRP) would improve outcomes more effectively than placebo (saline) after 3 months in patients with AT. Study Design: Randomized controlled trial; Level of evidence, 1. Methods: A total of 24 patients with chronic AT (median disease duration, 33 months) were randomized (1:1) to receive either a blinded injection of PRP (n = 12) or saline (n = 12). The primary endpoint was improvement in Victorian Institute of Sports Assessment-Achilles (VISA-A) score at 3 months. Secondary outcomes were pain at rest, pain while walking, pain when tendon was squeezed, ultrasonographic changes in tendon thickness, and color Doppler activity. Patients were informed that they could drop out after 3 months if they were dissatisfied with the treatment. Results: After 3 months, all 24 patients were reassessed (no dropouts). No difference between the PRP and the saline group could be observed with regard to the primary outcome (VISA-A score: mean difference [MD], -1.3; 95% CI, -17.8 to 15.2; P = .868). Secondary outcomes were pain at rest (MD, 1.6; 95% CI, -0.5 to 3.7; P = .137), pain while walking (MD, 0.8; 95% CI, -1.8 to 3.3; P = .544), pain when tendon was squeezed (MD, 0.3; 95% CI, -0.2 to 0.9; P = .208), color Doppler activity (MD, 0.3; 95% CI, -0.2 to 0.8; P = .260), and tendon thickness (MD, 0.8 mm; 95% CI, 0.1 to 1.6 mm; P = .030). After the 3-month follow-up, a large dropout was observed: 75% of patients in the PRP group and 33% in the saline group. Conclusion: PRP injection did not result in an improved VISA-A score over a 3-month period in patients with chronic AT compared with placebo. The only secondary outcome demonstrating a statistically significant difference between the groups was change in tendon thickness; this difference indicates that a PRP injection could increase tendon thickness compared with saline injection. The conclusions are limited to the 3 months after treatment owing to the large dropout rate.
引用
收藏
页码:1990 / 1997
页数:8
相关论文
共 50 条
  • [21] Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial
    Dorio, Murillo
    Rodrigues Pereira, Rosa Maria
    Branco Luz, Alexandre Galeno
    Deveza, Leticia Alle
    de Oliveira, Ricardo Manoel
    Fuller, Ricardo
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [22] Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial
    Murillo Dório
    Rosa Maria Rodrigues Pereira
    Alexandre Galeno Branco Luz
    Leticia Alle Deveza
    Ricardo Manoel de Oliveira
    Ricardo Fuller
    [J]. BMC Musculoskeletal Disorders, 22
  • [23] Achilles tendinopathy management A PILOT RANDOMISED CONTROLLED TRIAL COMPARING PLATELET-RICH PLASMA INJECTION WITH AN ECCENTRIC LOADING PROGRAMME
    Kearney, R. S.
    Parsons, N.
    Costa, M. L.
    [J]. BONE & JOINT RESEARCH, 2013, 2 (10): : 227 - 232
  • [24] Extracorporeal Shockwave Therapy Versus Platelet-rich Plasma for Achilles Tendinopathy
    Tenforde, Adam
    Robinson, David
    Borg-Stein, Joanne
    Borgstrom, Haylee
    Singh, Jaspal Ricky
    [J]. PM&R, 2020, 12 (11) : 1169 - 1176
  • [25] Ultrasound-Guided Percutaneous Needle Tenotomy with Platelet-Rich Plasma Injection for an Uncommon Case of Proximal Gluteus Medius Tendinopathy
    Hung, Chen-Yu
    Chang, Ke-Vin
    [J]. JOURNAL OF MEDICAL ULTRASOUND, 2019, 27 (02) : 111 - 112
  • [26] Ultrasound-Guided Platelet-Rich Plasma Injection in a Patient with a Plantar Fascia Tear
    Ozturk, Gokhan Tuna
    Ulasli, Alper Murat
    [J]. JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2017, 107 (06) : 565 - 567
  • [27] Ultrasound-guided injection of platelet-rich plasma in a patient with an ischeotibial muscle injury
    Andrea Gomez, Ling
    Bonilla Briceno, Javier Fernando
    Martinez Vasquez, Angelica Patricia
    Luisa Munoz, Ana
    [J]. RETOS-NUEVAS TENDENCIAS EN EDUCACION FISICA DEPORTE Y RECREACION, 2021, (41): : 209 - 213
  • [28] The Effectiveness of Platelet-Rich Plasma Injections in Gluteal Tendinopathy A Randomized, Double-Blind Controlled Trial Comparing a Single Platelet-Rich Plasma Injection With a Single Corticosteroid Injection
    Fitzpatrick, Jane
    Bulsara, Max K.
    O'Donnell, John
    McCrory, Paul Robert
    Zheng, Ming Hao
    [J]. AMERICAN JOURNAL OF SPORTS MEDICINE, 2018, 46 (04): : 933 - 939
  • [29] The effect of platelet-rich plasma injection on chronic Achilles tendinopathy and acute Achilles tendon rupture
    Chen, Jianguo
    Wan, Yingying
    Jiang, Haiyue
    [J]. PLATELETS, 2022, 33 (03) : 339 - 349
  • [30] Effect of Platelet-Rich Plasma Injection vs Sham Injection on Tendon Dysfunction in Patients With Chronic Midportion Achilles Tendinopathy A Randomized Clinical Trial
    Kearney, Rebecca S.
    Ji, Chen
    Warwick, Jane
    Parsons, Nicholas
    Brown, Jaclyn
    Harrison, Paul
    Young, Jonathan
    Costa, Matthew L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (02): : 137 - 144